Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1996-1-11
|
pubmed:abstractText |
Androgens are 19-carbon steroid rings. Progestagens include both 19-carbon and 21-carbon steroid rings; the 19-carbon progestagens are generally more androgenic than are the 21-carbon compounds. Both androgens and progestagens are physiological regulators of plasma lipids, particularly high-density lipoprotein (HDL) cholesterol. The structure of a particular hormonal preparation, as well as its route of administration, modulates its regulatory effects. Both endogenous and exogenous androgens have a suppressive effect on HDL cholesterol in males, with little effect on other plasma lipoproteins. Oral and nonaromatizable androgens have a greater suppressive effect on HDL cholesterol, particularly on HDL2, than do aromatizable androgens. Cross-sectional studies in males generally show a positive relationship between serum T and plasma HDL levels; data in females suggest an inverse relationship between androgens and HDL cholesterol. Medroxy-progesterone acetate and related progestagens have a mild suppressive effect on plasma HDL levels. The C-19 compounds have a greater suppressive effect on HDL cholesterol and the HDL2 density subfraction.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anabolic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Androgens,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Progestins
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0033-0620
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
255-71
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7494886-Aging,
pubmed-meshheading:7494886-Anabolic Agents,
pubmed-meshheading:7494886-Androgens,
pubmed-meshheading:7494886-Cholesterol, HDL,
pubmed-meshheading:7494886-Female,
pubmed-meshheading:7494886-Humans,
pubmed-meshheading:7494886-Hypogonadism,
pubmed-meshheading:7494886-Lipids,
pubmed-meshheading:7494886-Lipoproteins,
pubmed-meshheading:7494886-Male,
pubmed-meshheading:7494886-Progestins,
pubmed-meshheading:7494886-Puberty,
pubmed-meshheading:7494886-Puberty, Delayed,
pubmed-meshheading:7494886-Sex Characteristics
|
pubmed:articleTitle |
Androgen and progestagen effects on plasma lipids.
|
pubmed:affiliation |
Department of Medicine School of Medicine, University of Washington School of Medicine, USA.
|
pubmed:publicationType |
Journal Article,
Review
|